10-Q 1 forr-20240630.htm 10-Q 10-Q
trueQ2true0001023313--12-31truefalsetruetruetruehttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrentDec. 31, 2026http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#AccountingStandardsUpdate201613Member0001023313forr:ResearchServicesMember2024-04-012024-06-300001023313forr:ConsultingSegmentMemberforr:EventsRevenueMember2023-04-012023-06-300001023313us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001023313us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001023313us-gaap:TreasuryStockCommonMember2023-12-310001023313us-gaap:CommonStockMember2023-01-012023-06-300001023313forr:ResearchRevenueMember2023-04-012023-06-300001023313us-gaap:RetainedEarningsMember2023-12-310001023313forr:ResearchSegmentMemberforr:ConsultingServicesRevenueMember2023-04-012023-06-300001023313us-gaap:CommonStockMember2023-03-310001023313forr:ConsultingSegmentMember2023-01-012023-06-300001023313forr:ResearchServicesMember2023-04-012023-06-300001023313srt:NorthAmericaMember2024-04-012024-06-300001023313us-gaap:TreasuryStockCommonMember2023-04-012023-06-300001023313forr:ConsultingSegmentMember2023-04-012023-06-3000010233132024-03-310001023313us-gaap:OtherNonoperatingIncomeExpenseMember2024-04-012024-06-300001023313us-gaap:TreasuryStockCommonMember2024-06-300001023313forr:FederalAgencyObligationMember2024-06-300001023313us-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2026-12-310001023313forr:ConsultingSegmentMemberforr:EventsRevenueMember2024-04-012024-06-300001023313us-gaap:TechnologyBasedIntangibleAssetsMember2023-12-310001023313forr:ResearchSegmentMemberforr:ResearchRevenueMember2023-04-012023-06-300001023313us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-12-310001023313forr:WorkforceReductionInJanuaryTwoThousandTwentyThreeMember2024-06-300001023313forr:ResearchSegmentMemberforr:ConsultingServicesRevenueMember2023-01-012023-06-300001023313forr:ConsultingServicesRevenueMemberforr:ConsultingSegmentMember2023-04-012023-06-300001023313srt:NorthAmericaMember2024-01-012024-06-300001023313us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberforr:MarketableInvestmentsMember2023-12-310001023313us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310001023313us-gaap:LetterOfCreditMember2024-06-300001023313us-gaap:TreasuryStockCommonMember2023-01-012023-06-300001023313us-gaap:TechnologyBasedIntangibleAssetsMember2024-06-300001023313us-gaap:RevolvingCreditFacilityMember2024-01-012024-06-300001023313us-gaap:CorporateDebtSecuritiesMember2023-12-310001023313us-gaap:AccumulatedTranslationAdjustmentMember2024-04-012024-06-300001023313us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-01-012024-06-3000010233132023-03-3100010233132022-12-310001023313us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001023313us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001023313us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberforr:MarketableInvestmentsMember2024-06-300001023313forr:EventsRevenueMember2023-01-012023-06-300001023313forr:EventsSegmentMemberforr:ResearchRevenueMember2023-04-012023-06-300001023313forr:ResearchSegmentMemberforr:EventsRevenueMember2023-04-012023-06-300001023313forr:EventsRevenueMember2024-04-012024-06-300001023313srt:AsiaPacificMember2024-04-012024-06-300001023313forr:ConsultingServicesRevenueMemberforr:EventsSegmentMember2024-04-012024-06-300001023313us-gaap:CorporateDebtSecuritiesMember2023-12-310001023313us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001023313forr:ConsultingServicesRevenueMemberforr:EventsSegmentMember2024-01-012024-06-300001023313srt:EuropeMember2024-01-012024-06-300001023313us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-06-300001023313forr:ConsultingServicesRevenueMember2023-04-012023-06-300001023313us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-06-300001023313us-gaap:TreasuryStockCommonMember2023-06-300001023313us-gaap:EmployeeStockMember2024-04-012024-06-300001023313forr:ResearchSegmentMemberforr:EventsRevenueMember2024-01-012024-06-300001023313us-gaap:RetainedEarningsMember2023-04-012023-06-300001023313forr:ResearchSegmentMemberforr:EventsRevenueMember2023-01-012023-06-300001023313us-gaap:CommonStockMember2023-12-310001023313us-gaap:RetainedEarningsMember2024-01-012024-06-300001023313srt:EuropeMember2023-04-012023-06-300001023313us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-01-3100010233132024-01-012024-03-310001023313us-gaap:CorporateDebtSecuritiesMember2024-06-300001023313us-gaap:CommonStockMember2022-12-310001023313us-gaap:AccountingStandardsUpdate201912Member2024-03-310001023313us-gaap:CommonStockMember2023-06-300001023313us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001023313forr:ConsultingServicesRevenueMemberforr:ConsultingSegmentMember2024-01-012024-06-300001023313srt:EuropeMember2024-04-012024-06-300001023313us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300001023313us-gaap:AccountingStandardsUpdate202307Member2024-03-310001023313us-gaap:PrivateEquityFundsDomesticMemberforr:CashAndCashEquivalentMember2024-06-300001023313us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberforr:MarketableInvestmentsMember2024-06-300001023313us-gaap:CostOfSalesMember2024-01-012024-06-300001023313us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-06-300001023313us-gaap:AdditionalPaidInCapitalMember2023-03-310001023313forr:ResearchSegmentMember2023-04-012023-06-300001023313us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-06-300001023313us-gaap:SellingAndMarketingExpenseMember2024-01-012024-06-300001023313forr:FederalAgencyObligationMember2023-12-310001023313srt:EuropeMember2023-01-012023-06-300001023313us-gaap:CostOfSalesMember2023-01-012023-06-300001023313us-gaap:PrivateEquityFundsDomesticMemberforr:CashAndCashEquivalentMember2023-12-3100010233132023-01-012023-03-310001023313forr:FederalAgencyObligationMember2024-06-300001023313us-gaap:FairValueMeasurementsRecurringMember2023-12-310001023313us-gaap:AccumulatedTranslationAdjustmentMember2024-06-300001023313forr:ConsultingServicesRevenueMemberforr:EventsSegmentMember2023-04-012023-06-300001023313us-gaap:CommonStockMember2023-04-012023-06-300001023313us-gaap:AccumulatedTranslationAdjustmentMember2023-04-012023-06-300001023313forr:ConsultingSegmentMember2024-06-300001023313forr:EventsSegmentMember2024-04-012024-06-300001023313us-gaap:EmployeeStockMember2024-01-012024-06-300001023313srt:NorthAmericaMember2023-01-012023-06-300001023313stpr:CA2023-01-012023-06-300001023313forr:EventsSegmentMemberforr:ResearchRevenueMember2023-01-012023-06-300001023313forr:WorkforceReductionInFebruaryTwoThousandTwentyFourMember2024-01-012024-06-300001023313us-gaap:OtherNonoperatingIncomeExpenseMember2023-04-012023-06-300001023313us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-03-310001023313forr:EventsSegmentMember2023-04-012023-06-300001023313forr:FederalAgencyObligationMember2023-12-310001023313forr:WorkforceReductionInMayTwoThousandTwentyThreeMember2024-06-300001023313forr:EventsSegmentMemberforr:ResearchRevenueMember2024-04-012024-06-300001023313us-gaap:EmployeeStockOptionMember2023-04-012023-06-300001023313us-gaap:AccountingStandardsUpdate202101Member2024-03-310001023313forr:ResearchRevenueMember2023-01-012023-06-300001023313forr:WorkforceReductionInMayTwoThousandTwentyThreeMember2024-01-012024-06-300001023313forr:EventsRevenueMember2023-04-012023-06-300001023313us-gaap:GeneralAndAdministrativeExpenseMember2023-04-012023-06-300001023313srt:AsiaPacificMember2023-01-012023-06-300001023313us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001023313forr:ConsultingSegmentMemberforr:EventsRevenueMember2023-01-012023-06-300001023313forr:EventsSegmentMemberforr:EventsRevenueMember2023-04-012023-06-300001023313forr:ResearchSegmentMemberforr:EventsRevenueMember2024-04-012024-06-300001023313us-gaap:AdditionalPaidInCapitalMember2023-12-310001023313us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310001023313us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001023313us-gaap:SellingAndMarketingExpenseMember2023-04-012023-06-300001023313us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310001023313us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-04-012023-06-300001023313forr:ResearchRevenueMemberforr:ConsultingSegmentMember2023-01-012023-06-300001023313forr:ResearchSegmentMemberforr:ResearchRevenueMember2023-01-012023-06-300001023313us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-300001023313us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001023313us-gaap:RetainedEarningsMember2023-01-012023-06-300001023313forr:ResearchRevenueMember2024-04-012024-06-300001023313srt:AsiaPacificMember2023-04-012023-06-300001023313forr:ConsultingServicesRevenueMember2024-04-012024-06-300001023313us-gaap:OtherNonoperatingIncomeExpenseMember2023-01-012023-06-300001023313forr:EventsRevenueMember2024-01-012024-06-300001023313us-gaap:CustomerRelationshipsMember2024-06-300001023313us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-06-300001023313us-gaap:TrademarksMember2023-12-3100010233132023-01-012023-01-310001023313stpr:CA2023-01-012023-03-310001023313us-gaap:PrivateEquityFundsForeignMemberforr:MarketableInvestmentMember2023-12-310001023313us-gaap:RetainedEarningsMember2024-06-3000010233132024-06-300001023313us-gaap:TrademarksMember2024-06-300001023313forr:EventsSegmentMemberforr:EventsRevenueMember2024-04-012024-06-300001023313us-gaap:GeneralAndAdministrativeExpenseMember2024-01-012024-06-300001023313us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001023313forr:ConsultingSegmentMember2024-01-012024-06-300001023313forr:OtherCountryMember2024-01-012024-06-300001023313us-gaap:TreasuryStockCommonMember2024-03-310001023313forr:WorkforceReductionInJanuaryTwoThousandTwentyThreeMember2024-01-012024-06-3000010233132024-07-300001023313forr:ConsultingServicesRevenueMemberforr:ConsultingSegmentMember2024-04-012024-06-3000010233132021-10-01srt:MaximumMember2024-06-300001023313us-gaap:CommonStockMember2024-01-012024-06-300001023313forr:WorkforceReductionInFebruaryTwoThousandTwentyFourMember2023-12-310001023313us-gaap:AdditionalPaidInCapitalMember2024-01-012024-06-300001023313us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001023313us-gaap:CorporateDebtSecuritiesMember2024-06-300001023313forr:OtherCountryMember2023-01-012023-06-3000010233132023-04-012023-06-300001023313forr:OtherCountryMember2023-04-012023-06-300001023313us-gaap:RestrictedStockUnitsRSUMember2024-06-300001023313us-gaap:TreasuryStockCommonMember2022-12-310001023313us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-3000010233132024-04-300001023313us-gaap:EmployeeStockMember2023-01-012023-06-300001023313forr:ResearchRevenueMemberforr:ConsultingSegmentMember2024-01-012024-06-300001023313us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-3100010233132023-12-310001023313us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001023313us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300001023313us-gaap:CommonStockMember2024-04-012024-06-300001023313us-gaap:EmployeeStockOptionMember2023-01-012023-06-300001023313forr:ResearchSegmentMember2024-04-012024-06-300001023313forr:ResearchRevenueMemberforr:ConsultingSegmentMember2024-04-012024-06-300001023313forr:OtherCountryMember2024-04-012024-06-300001023313us-gaap:MoneyMarketFundsMember2024-06-300001023313us-gaap:TreasuryStockCommonMember2024-01-012024-06-300001023313forr:ConsultingSegmentMemberforr:EventsRevenueMember2024-01-012024-06-300001023313us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001023313us-gaap:AdditionalPaidInCapitalMember2023-06-300001023313forr:ResearchServicesMember2023-01-012023-06-300001023313us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001023313us-gaap:FairValueMeasurementsRecurringMember2024-06-300001023313us-gaap:FairValueMeasurementsRecurringMemberforr:MarketableInvestmentsMember2023-12-310001023313us-gaap:RestrictedStockUnitsRSUMember2023-12-3100010233132024-01-012024-06-300001023313us-gaap:RetainedEarningsMember2024-04-012024-06-3000010233132023-06-300001023313srt:MaximumMember2024-01-012024-06-300001023313forr:WorkforceReductionInMayTwoThousandTwentyThreeMember2023-12-310001023313us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001023313srt:NorthAmericaMember2023-04-012023-06-300001023313us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001023313us-gaap:AdditionalPaidInCapitalMember2024-06-300001023313us-gaap:CommonStockMember2024-03-310001023313forr:ConsultingSegmentMember2024-04-012024-06-3000010233132024-04-012024-06-300001023313us-gaap:OtherNonoperatingIncomeExpenseMember2024-01-012024-06-300001023313forr:ConsultingServicesRevenueMemberforr:EventsSegmentMember2023-01-012023-06-300001023313us-gaap:AdditionalPaidInCapitalMember2024-03-310001023313forr:EventsSegmentMemberforr:ResearchRevenueMember2024-01-012024-06-300001023313srt:AsiaPacificMember2024-01-012024-06-300001023313us-gaap:MoneyMarketFundsMember2023-12-310001023313forr:ConsultingServicesRevenueMember2024-01-012024-06-300001023313us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-06-300001023313us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001023313forr:ResearchSegmentMemberforr:ConsultingServicesRevenueMember2024-04-012024-06-300001023313us-gaap:RetainedEarningsMember2022-12-310001023313us-gaap:CommonStockMember2024-06-300001023313forr:ResearchSegmentMember2023-01-012023-06-300001023313us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-03-3100010233132023-05-012023-05-310001023313us-gaap:TreasuryStockCommonMember2024-04-012024-06-300001023313forr:ResearchRevenueMemberforr:ConsultingSegmentMember2023-04-012023-06-300001023313forr:ConsultingServicesRevenueMember2023-01-012023-06-3000010233132023-10-012023-12-310001023313us-gaap:LeaseholdImprovementsMemberstpr:CA2024-01-012024-06-300001023313us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberforr:MarketableInvestmentsMember2023-12-310001023313us-gaap:RetainedEarningsMember2024-03-310001023313us-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2024-06-300001023313us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001023313us-gaap:PrivateEquityFundsForeignMemberforr:MarketableInvestmentMember2024-06-300001023313forr:EventsSegmentMember2024-01-012024-06-300001023313us-gaap:RetainedEarningsMember2023-06-300001023313us-gaap:EmployeeStockMember2023-04-012023-06-300001023313forr:EventsSegmentMemberforr:EventsRevenueMember2024-01-012024-06-300001023313us-gaap:TreasuryStockCommonMember2023-03-310001023313us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001023313us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-06-300001023313us-gaap:GeneralAndAdministrativeExpenseMember2024-04-012024-06-300001023313us-gaap:AdditionalPaidInCapitalMember2022-12-310001023313us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001023313forr:ConsultingServicesRevenueMemberforr:ConsultingSegmentMember2023-01-012023-06-300001023313forr:WorkforceReductionInFebruaryTwoThousandTwentyFourMember2024-06-300001023313forr:EventsSegmentMember2023-01-012023-06-300001023313us-gaap:CustomerRelationshipsMember2023-12-310001023313us-gaap:CostOfSalesMember2024-04-012024-06-300001023313us-gaap:FairValueMeasurementsRecurringMemberforr:MarketableInvestmentsMember2024-06-300001023313us-gaap:AdditionalPaidInCapitalMember2023-01-012023-06-3000010233132022-10-012022-12-310001023313forr:ResearchSegmentMemberforr:ResearchRevenueMember2024-01-012024-06-3000010233132023-01-012023-06-300001023313forr:ResearchSegmentMember2024-01-012024-06-300001023313forr:ResearchSegmentMemberforr:ConsultingServicesRevenueMember2024-01-012024-06-300001023313forr:EventsSegmentMemberforr:EventsRevenueMember2023-01-012023-06-300001023313us-gaap:SellingAndMarketingExpenseMember2024-04-012024-06-300001023313us-gaap:CostOfSalesMember2023-04-012023-06-300001023313forr:ResearchServicesMember2024-01-012024-06-300001023313forr:ResearchRevenueMember2024-01-012024-06-300001023313forr:ResearchSegmentMemberforr:ResearchRevenueMember2024-04-012024-06-300001023313us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-04-012024-06-300001023313forr:WorkforceReductionInJanuaryTwoThousandTwentyThreeMember2023-12-310001023313us-gaap:RetainedEarningsMember2023-03-310001023313us-gaap:SellingAndMarketingExpenseMember2023-01-012023-06-30xbrli:pureiso4217:USDxbrli:sharesxbrli:sharesiso4217:USDforr:Segment

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(MARK ONE)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934.

FOR THE QUARTERLY PERIOD ENDED June 30, 2024

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934.

COMMISSION FILE NUMBER: 000-21433

 

FORRESTER RESEARCH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

04-2797789

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

60 Acorn Park Drive

Cambridge, Massachusetts

 

02140

(Zip Code)

(Address of principal executive offices)

 

 

 

(617) 613-6000

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

 

Trading Symbol(s)

 

Name of Each Exchange on Which Registered

Common Stock, $.01 Par Value

 

FORR

 

Nasdaq Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

 

Accelerated filer

 

Non-accelerated filer

 

 

Smaller reporting company

 

Emerging growth company

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

As of July 30, 2024, 19,060,000 shares of the registrant’s common stock were outstanding.

 


 

FORRESTER RESEARCH, INC.

INDEX TO FORM 10-Q

 

 

Page

PART I

FINANCIAL INFORMATION

Item 1.

Financial Statements (Unaudited)

3

 

Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023

3

 

Consolidated Statements of Operations for the three and six months ended June 30, 2024 and 2023

4

 

Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended June 30, 2024 and 2023

5

 

Consolidated Statements of Cash Flows for the six months ended June 30, 2024 and 2023

6

 

Notes to Consolidated Financial Statements

7

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

21

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

30

Item 4.

Controls and Procedures

30

 

PART II

OTHER INFORMATION

 

Item 1.

Legal Proceedings

31

Item 1A.

Risk Factors

31

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

31

Item 3.

Defaults Upon Senior Securities

31

Item 4.

Mine Safety Disclosures

31

Item 5.

Other Information

31

Item 6.

Exhibits

32

 

 

 

SIGNATURES

33

 

 

 

 

 


 

PART I.

ITEM 1. FINANCIAL STATEMENTS

FORRESTER RESEARCH, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data, unaudited)

 

 

 

June 30,

 

 

December 31,

 

 

 

2024

 

 

2023

 

ASSETS

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

58,852

 

 

$

72,909

 

Marketable investments

 

 

51,961

 

 

 

51,580

 

Accounts receivable, net of allowance for expected credit losses of $753 and $574 as
   of June 30, 2024 and December 31, 2023, respectively

 

 

47,702

 

 

 

58,999

 

Deferred commissions

 

 

18,159

 

 

 

23,207

 

Prepaid expenses and other current assets

 

 

16,753

 

 

 

9,305

 

Total current assets

 

 

193,427

 

 

 

216,000

 

Property and equipment, net

 

 

16,610

 

 

 

19,401

 

Operating lease right-of-use assets

 

 

32,083

 

 

 

39,722

 

Goodwill

 

 

242,924

 

 

 

244,257

 

Intangible assets, net

 

 

32,562

 

 

 

37,637

 

Other assets

 

 

6,561

 

 

 

7,157

 

Total assets

 

$

524,167

 

 

$

564,174

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

Accounts payable

 

$

2,329

 

 

$

1,796

 

Accrued expenses and other current liabilities

 

 

45,148

 

 

 

81,482

 

Deferred revenue

 

 

164,117

 

 

 

156,798

 

Total current liabilities

 

 

211,594

 

 

 

240,076

 

Long-term debt

 

 

35,000

 

 

 

35,000

 

Non-current operating lease liabilities

 

 

31,338

 

 

 

37,673

 

Other non-current liabilities

 

 

9,181

 

 

 

11,160

 

Total liabilities

 

 

287,113

 

 

 

323,909

 

Commitments and contingencies (Note 15)

 

 

 

 

 

 

Stockholders' Equity:

 

 

 

 

 

 

Preferred stock, $0.01 par value

 

 

 

 

 

 

Authorized - 500 shares; issued and outstanding - none

 

 

 

 

 

 

Common stock, $0.01 par value

 

 

 

 

 

 

Authorized - 125,000 shares

 

 

 

 

 

 

Issued - 24,897 and 24,684 shares as of June 30, 2024 and December 31, 2023,
   respectively

 

 

 

 

 

 

Outstanding - 19,056 and 19,248 shares as of June 30, 2024 and
   December 31, 2023, respectively

 

 

249

 

 

 

247

 

Additional paid-in capital

 

 

285,395

 

 

 

278,057

 

Retained earnings

 

 

177,300

 

 

 

177,681

 

Treasury stock - 5,841 and 5,437 shares as of June 30, 2024 and December 31, 2023,
respectively

 

 

(219,164

)

 

 

(211,149

)

Accumulated other comprehensive loss

 

 

(6,726

)

 

 

(4,571

)

Total stockholders’ equity

 

 

237,054

 

 

 

240,265

 

Total liabilities and stockholders’ equity

 

$

524,167

 

 

$

564,174

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

3


 

FORRESTER RESEARCH, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data, unaudited)

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

Research

 

$

83,663

 

 

$

87,699

 

 

$

160,244

 

 

$

168,605

 

Consulting

 

 

24,811

 

 

 

29,970

 

 

 

47,952

 

 

 

61,720

 

Events

 

 

13,351

 

 

 

17,920

 

 

 

13,706

 

 

 

18,934

 

Total revenues

 

 

121,825

 

 

 

135,589

 

 

 

221,902

 

 

 

249,259

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of services and fulfillment

 

 

51,164

 

 

 

54,614

 

 

 

95,854

 

 

 

103,906

 

Selling and marketing

 

 

40,253

 

 

 

41,581

 

 

 

79,675

 

 

 

83,113

 

General and administrative

 

 

14,437

 

 

 

15,315

 

 

 

28,496

 

 

 

36,542

 

Depreciation

 

 

2,062

 

 

 

2,191

 

 

 

4,122

 

 

 

4,295

 

Amortization of intangible assets

 

 

2,513

 

 

 

3,068

 

 

 

5,027

 

 

 

6,134

 

Restructuring costs

 

 

82

 

 

 

10,532

 

 

 

6,706

 

 

 

12,121

 

Total operating expenses

 

 

110,511

 

 

 

127,301

 

 

 

219,880

 

 

 

246,111

 

Income from operations

 

 

11,314

 

 

 

8,288

 

 

 

2,022

 

 

 

3,148

 

Interest expense

 

 

(763

)

 

 

(730

)

 

 

(1,525

)

 

 

(1,523

)

Other income, net

 

 

1,015

 

 

 

514

 

 

 

2,289

 

 

 

1,064

 

Income before income taxes

 

 

11,566

 

 

 

8,072

 

 

 

2,786

 

 

 

2,689

 

Income tax expense

 

 

5,274

 

 

 

2,768

 

 

 

3,167

 

 

 

1,460

 

Net income (loss)

 

$

6,292

 

 

$

5,304

 

 

$

(381

)

 

$

1,229

 

Basic income (loss) per common share

 

$

0.33

 

 

$

0.28

 

 

$

(0.02

)

 

$

0.06

 

Diluted income (loss) per common share

 

$

0.33

 

 

$

0.28

 

 

$

(0.02

)

 

$

0.06

 

Basic weighted average common shares outstanding

 

 

19,093

 

 

 

19,193

 

 

 

19,189

 

 

 

19,151

 

Diluted weighted average common shares outstanding

 

 

19,124

 

 

 

19,258

 

 

 

19,189

 

 

 

19,214

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

4


 

FORRESTER RESEARCH, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In thousands, unaudited)

 

 

Three Months Ended

 

 

Six Months Ended

 

 

June 30,

 

 

June 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Net income (loss)

$

6,292

 

 

$

5,304

 

 

$

(381

)

 

$

1,229

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation

 

(211

)

 

 

746

 

 

 

(2,179

)

 

 

1,952

 

Net change in market value of investments

 

18

 

 

 

(11

)

 

 

24

 

 

 

22

 

Other comprehensive income (loss)

 

(193

)

 

 

735

 

 

 

(2,155

)

 

 

1,974

 

Comprehensive income (loss)

$

6,099

 

 

$

6,039

 

 

$

(2,536

)

 

$

3,203

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

5


 

FORRESTER RESEARCH, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, unaudited)

 

 

Six Months Ended

 

 

June 30,

 

 

2024

 

 

2023

 

Cash flows from operating activities:

 

 

 

 

 

Net income (loss)

$

(381

)

 

$

1,229

 

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

 

 

 

 

 

Depreciation

 

4,122

 

 

 

4,295

 

Impairment of property and equipment

 

646

 

 

 

600

 

Amortization of intangible assets

 

5,027

 

 

 

6,134

 

Deferred income taxes

 

(1,035

)

 

 

(1,479

)

Stock-based compensation

 

7,599

 

 

 

7,025

 

Operating lease right-of-use assets amortization and impairments

 

7,983

 

 

 

6,691

 

Other, net

 

79

 

 

 

137

 

Changes in assets and liabilities:

 

 

 

 

 

Accounts receivable

 

10,773

 

 

 

27,391

 

Deferred commissions

 

5,048

 

 

 

6,299

 

Prepaid expenses and other current assets

 

(7,298

)

 

 

(7,122

)

Accounts payable

 

552

 

 

 

767

 

Accrued expenses and other liabilities

 

(35,100

)

 

 

(28,824

)

Deferred revenue

 

6,960

 

 

 

(535

)

Operating lease liabilities

 

(7,270

)

 

 

(6,820

)

Net cash provided by (used in) operating activities

 

(2,295

)

 

 

15,788

 

Cash flows from investing activities:

 

 

 

 

 

Purchases of property and equipment

 

(2,256

)

 

 

(2,664

)

Purchases of marketable investments

 

(51,837

)

 

 

(964

)

Proceeds from maturities of marketable investments

 

45,235

 

 

 

7,138

 

Proceeds from sales of marketable investments

 

6,168

 

 

 

 

Other investing activity

 

14

 

 

 

(66

)

Net cash provided by (used in) investing activities

 

(2,676

)

 

 

3,444

 

Cash flows from financing activities:

 

 

 

 

 

Payments on borrowings

 

 

 

 

(15,000

)

Repurchases of common stock

 

(8,015

)

 

 

(820

)

Proceeds from issuance of common stock under employee equity incentive plans

 

1,253

 

 

 

1,840

 

Taxes paid related to net share settlements of stock-based compensation awards

 

(1,512

)

 

 

(1,259

)

Net cash used in financing activities

 

(8,274

)

 

 

(15,239

)

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

(828

)

 

 

2,424

 

Net change in cash, cash equivalents and restricted cash

 

(14,073

)

 

 

6,417

 

Cash, cash equivalents and restricted cash, beginning of period

 

75,042

 

 

 

105,654

 

Cash, cash equivalents and restricted cash, end of period

$

60,969

 

 

$

112,071

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

Cash paid for interest

$

1,301

 

 

$

1,302

 

Cash paid for income taxes

$

6,978

 

 

$

9,729

 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

6


 

FORRESTER RESEARCH, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

 

Note 1 — Interim Consolidated Financial Statements

Basis of Presentation

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for reporting on Form 10-Q. Accordingly, certain information and footnote disclosures required for complete financial statements are not included herein. The year-end balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. It is recommended that these financial statements be read in conjunction with the consolidated financial statements and related notes that appear in the Forrester Research, Inc. (“Forrester”) Annual Report on Form 10-K for the year ended December 31, 2023. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the financial position, results of operations, comprehensive income (loss), and cash flows as of the dates and for the periods presented have been included. The results of operations for the three and six months ended June 30, 2024 may not be indicative of the results for the year ending December 31, 2024, or any other period.

Presentation of Restricted Cash

The following table summarizes the end-of-period cash and cash equivalents from the Company's Consolidated Balance Sheets and the total cash, cash equivalents and restricted cash as presented on the accompanying Consolidated Statements of Cash Flows (in thousands).

 

 

Six Months Ended June 30,

 

 

2024

 

 

2023

 

Cash and cash equivalents shown in balance sheets

$

58,852

 

 

$

109,951

 

Restricted cash classified in other assets (1):

 

2,117

 

 

 

2,120

 

Cash, cash equivalents and restricted cash shown in statement of cash flows

$

60,969

 

 

$

112,071

 

 

(1)
Restricted cash consists of collateral required for leased office space. The short-term or long-term classification regarding the collateral for the leased office space is determined in accordance with the expiration of the underlying leases.

Recent Accounting Pronouncements

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures. The new standard enhances the disclosures of reportable segment information, primarily in regards to significant segment expenses. The new standard will be effective for the Company for the annual periods beginning January 1, 2024, and for interim periods beginning January 1, 2025, with early adoption permitted. Upon adoption, the guidance should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of adoption of the standard on its consolidated financial statements.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures. The new standard enhances income tax disclosure requirements by requiring specified categories and greater disaggregation within the rate reconciliation table, disclosure of income taxes paid by jurisdiction, and providing clarification on uncertain tax positions and related financial statement impacts. The new standard will be effective for the Company on January 1, 2025, with early adoption permitted. The Company is currently evaluating the impact of adoption of the standard on its consolidated financial statements.

 

7


 

Note 2 — Marketable Investments

The following table summarizes the Company’s marketable investments (in thousands):

 

 

As of June 30, 2024

 

 

 

 

 

 

Gross

 

 

Gross

 

 

 

 

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Market

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Value

 

Corporate obligations

 

$

15,264

 

 

$

2

 

 

$

(46

)

 

$

15,220

 

Federal agency obligations

 

 

1,500

 

 

 

 

 

 

(3

)

 

 

1,497

 

Money market funds

 

 

35,244

 

 

 

 

 

 

 

 

 

35,244

 

Total

 

$

52,008

 

 

$

2

 

 

$

(49

)

 

$

51,961

 

 

 

 

As of December 31, 2023

 

 

 

 

 

 

Gross

 

 

Gross

 

 

 

 

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Market

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Value

 

Corporate obligations

 

$

18,049

 

 

$

 

 

$

(72

)

 

$

17,977

 

Federal agency obligations

 

 

2,000

 

 

 

 

 

 

(7

)

 

 

1,993

 

Money market funds

 

 

31,610

 

 

 

 

 

 

 

 

 

31,610

 

Total

 

$

51,659

 

 

$

 

 

$

(79

)

 

$

51,580

 

Realized gains and losses on investments are included in earnings and are determined using the specific identification method. Sales of marketable investments during 2024 primarily represent redemptions from non-U.S. based money market funds, and there were no realized gains or loss on sales of marketable investments during the three and six months ended June 30, 2024 and 2023.

The following table summarizes the maturity periods of the marketable investments in the Company’s portfolio as of June 30, 2024 (in thousands).

 

 

FY 2024

 

 

FY 2025

 

 

FY 2026

 

 

FY 2027

 

 

Total

 

Corporate obligations

 

$

4,966

 

 

$

5,512

 

 

$

4,243

 

 

$

499

 

 

$

15,220

 

Federal agency obligations

 

 

997

 

 

 

 

 

 

 

 

 

500

 

 

 

1,497

 

Money market funds

 

 

35,244

 

 

 

 

 

 

 

 

 

 

 

 

35,244

 

Total

 

$

41,207

 

 

$

5,512

 

 

$

4,243

 

 

$

999

 

 

$

51,961

 

 

The following table shows the gross unrealized losses and market value of the Company’s available-for-sale securities with unrealized losses that are not deemed to be other-than-temporary, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position (in thousands):

 

 

As of June 30, 2024

 

 

 

Less Than 12 Months

 

 

12 Months or Greater

 

 

 

Market

 

 

Unrealized

 

 

Market

 

 

Unrealized

 

 

 

Value

 

 

Losses

 

 

Value

 

 

Losses

 

Corporate obligations

 

$

8,787

 

 

$

13

 

 

$

4,930

 

 

$

33

 

Federal agency obligations

 

 

 

 

 

 

 

 

997

 

 

 

3

 

Total

 

$

8,787

 

 

$

13

 

 

$

5,927

 

 

$

36

 

 

 

 

As of December 31, 2023

 

 

 

Less Than 12 Months

 

 

12 Months or Greater

 

 

 

Market

 

 

Unrealized

 

 

Market

 

 

Unrealized

 

 

 

Value

 

 

Losses

 

 

Value

 

 

Losses

 

Corporate obligations

 

$

13,098

 

 

$

8

 

 

$

4,879

 

 

$

64

 

Federal agency obligations

 

 

 

 

 

 

 

 

1,993

 

 

 

7

 

Total

 

$

13,098

 

 

$

8

 

 

$

6,872

 

 

$

71

 

 

 

8


 

Note 3 — Goodwill and Other Intangible Assets

Goodwill

Goodwill represents the excess of the purchase price of acquired businesses over the estimated fair values of the tangible and identifiable intangible net assets acquired. Goodwill is not amortized; however, it is required to be tested for impairment annually, which requires assessment of the potential impairment at the reporting unit level. Reporting units are determined based on the components of the Company's operating segments that constitute a business for which discrete financial information is available and for which operating results are regularly reviewed by segment management. Testing for impairment is also required on an interim basis if an event or circumstance indicates it is more likely than not an impairment loss has been incurred.

The Company performed its annual impairment testing as of November 30, 2023 utilizing a quantitative assessment to determine if the fair values of each of its reporting units was less than their respective carrying values and concluded that no impairments existed. Subsequent to completing the annual test and through June 30, 2024, there were no events or circumstances that required an interim impairment test. Accordingly, as of June 30, 2024, the Company had no accumulated goodwill impairment losses. Approximately $8.2 million of goodwill is allocated to the Company’s Consulting reporting unit, which had a negative carrying value as of the date of the last test.

 

The change in the carrying amount of goodwill for the six months ended June 30, 2024 is summarized as follows (in thousands):

 

Total

 

Balance at December 31, 2023

$

244,257

 

Translation adjustments

 

(1,333

)

Balance at June 30, 2024

$

242,924

 

Finite-Lived Intangible Assets

The carrying values of finite-lived intangible assets are as follows (in thousands):

 

 

June 30, 2024

 

 

Gross

 

 

 

 

 

Net

 

 

Carrying

 

 

Accumulated

 

 

Carrying

 

 

Amount

 

 

Amortization

 

 

Amount

 

Amortizable intangible assets:

 

 

 

 

 

 

 

 

Customer relationships

$

77,622

 

 

$

46,281

 

 

$

31,341

 

Technology

 

16,299

 

 

 

16,019

 

 

 

280

 

Trademarks

 

12,485

 

 

 

11,544

 

 

 

941

 

Total

$

106,406

 

 

$

73,844

 

 

$

32,562

 

 

 

December 31, 2023

 

 

Gross

 

 

 

 

 

Net

 

 

Carrying

 

 

Accumulated

 

 

Carrying

 

 

Amount

 

 

Amortization

 

 

Amount

 

Amortizable intangible assets:

 

 

 

 

 

 

 

 

Customer relationships

$

77,640

 

 

$

42,091

 

 

$

35,549

 

Technology

 

16,524

 

 

 

15,950

 

 

 

574

 

Trademarks

 

12,519

 

 

 

11,005

 

 

 

1,514

 

Total

$

106,683

 

 

$

69,046

 

 

$

37,637

 

 

Estimated intangible asset amortization expense for each of the five succeeding years is as follows (in thousands):

 

2024 (remainder)

$

4,890

 

2025

 

8,874

 

2026

 

8,392

 

2027

 

8,324

 

2028

 

2,082

 

Total

$

32,562

 

 

 

9


 

Note 4 — Debt

The Company has a credit facility that provides up to $150.0 million of revolving credit commitments and matures in December of 2026. The credit facility includes an expansion feature that permits the Company to increase the revolving credit commitments in an aggregate principal amount up to $50.0 million, subject to approval by the administrative agent and certain customary terms and conditions.

The credit facility contains certain customary restrictive loan covenants, including among others, financial covenants that apply a maximum leverage ratio, minimum interest coverage ratio, and maximum annual capital expenditures. The negative covenants limit, subject to various exceptions, the Company’s ability to incur additional indebtedness, create liens on assets, merge, consolidate, liquidate or dissolve any part of the Company, sell assets, change fiscal year, or enter into certain transactions with affiliates and subsidiaries. The Company was in full compliance with the covenants as of June 30, 2024.

The Company may voluntarily prepay revolving loans under the credit facility at any time and from time to time, without premium or penalty. No interim amortization payments are required to be made under the credit facility.

The credit facility provided that once LIBOR ceased to exist in 2023, the benchmark rate for the loans outstanding automatically transferred from LIBOR to the Secured Overnight Financing Rate (SOFR). In April 2023, the Company executed a second amendment to the credit facility to facilitate the conversion from LIBOR to SOFR and to set the base interest rate at SOFR plus 10 basis points.

Up to $5.0 million of the credit facility is available for the issuance of letters of credit, and any drawings under the letters of credit must be reimbursed within one business day. As of June 30, 2024, $0.6 million in letters of credit were issued under the credit facility.

Outstanding Borrowings

The following table summarizes the Company’s total outstanding borrowings as of the dates indicated (in thousands):

Description:

 

June 30, 2024

 

 

December 31, 2023

 

Credit facility

 

$

35,000

 

 

$

35,000

 

The contractual annualized interest rate as of June 30, 2024 was 6.69%.

The Company had $114.4 million of available borrowing capacity on the credit facility (not including the expansion feature) as of June 30, 2024. The weighted average annual effective interest rate for the three and six months ended June 30, 2024, was 6.68% and 6.67%, respectively.

All obligations under the credit facility are unconditionally guaranteed by each of the Company’s existing and future, direct and indirect, material wholly-owned domestic subsidiaries, other than certain excluded subsidiaries, and are collateralized by a first priority lien on substantially all tangible and intangible assets, including intellectual property, and all of the capital stock of the Company's subsidiaries (limited to 65% of the voting equity of certain subsidiaries).

Note 5 — Leases

All of the Company’s leases are operating leases, the majority of which are for office space. Operating lease right-of-use (“ROU”) assets and non-current operating lease liabilities are included as individual line items in the Consolidated Balance Sheets, while short-term operating lease liabilities are recorded within accrued expenses and other current liabilities. Leases with an initial term of twelve months or less are not recorded in the Consolidated Balance Sheets and are not material.

The components of lease expense were as follows (in thousands):

 

 

 

For the Three Months Ended June 30,

 

 

 

2024

 

 

2023

 

Operating lease cost

 

$

2,897

 

 

$

3,240

 

Short-term lease cost

 

 

231

 

 

 

257

 

Variable lease cost

 

 

1,038

 

 

 

1,072

 

Sublease income

 

 

(130

)

 

 

(130

)

Total lease cost

 

$

4,036

 

 

$

4,439

 

 

 

10


 

 

 

 

For the Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

Operating lease cost

 

$

5,991

 

 

$

6,554

 

Short-term lease cost

 

 

446

 

 

 

518

 

Variable lease cost

 

 

2,268

 

 

 

1,857

 

Sublease income

 

 

(261

)

 

 

(261

)

Total lease cost

 

$

8,444

 

 

$

8,668

 

 

Additional lease information is summarized in the following table (in thousands, except lease term and discount rate):

 

 

 

For the Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

Cash paid for amounts included in the measurement of operating
   lease liabilities

 

$

7,270

 

 

$

6,820

 

Operating lease ROU assets obtained in exchange for lease
   obligations

 

$

408

 

 

$

1,110

 

Weighted-average remaining lease term - operating leases (years)

 

 

4.0

 

 

 

4.7

 

Weighted-average discount rate - operating leases

 

 

4.2

%

 

 

4.3

%

 

Future minimum lease payments under non-cancelable leases and estimated future sublease cash receipts from non-cancelable arrangements as of June 30, 2024 are as follows (in thousands):

 

 

 

Operating Lease

 

 

Sublease

 

 

 

Payments

 

 

Cash Receipts

 

2024 (remainder)

 

$

8,073

 

 

$

316

 

2025

 

 

13,943

 

 

 

 

2026

 

 

12,333

 

 

 

 

2027

 

 

5,711

 

 

 

 

2028

 

 

2,878

 

 

 

 

Thereafter

 

 

6,030

 

 

 

 

Total lease payments and estimated sublease cash receipts

 

 

48,968

 

 

$

316

 

Less imputed interest

 

 

(4,040

)

 

 

 

Present value of lease liabilities

 

$

44,928

 

 

 

 

 

Lease balances as of June 30, 2024 are as follows (in thousands):

 

Operating lease ROU assets

 

$

32,083

 

 

 

 

 

Short-term operating lease liabilities (1)

 

$

13,590

 

Non-current operating lease liabilities

 

 

31,338

 

Total operating lease liabilities

 

$

44,928

 

 

(1)
Included in accrued expenses and other current liabilities in the Consolidated Balance Sheets.

The Company’s leases do not contain residual value guarantees, material restrictions, or covenants.

During the six months ended June 30, 2024, the Company recorded a $3.2 million ROU asset impairment and $0.6 million of leasehold improvements impairments related to closing the 11th floor of its offices located in San Francisco, California. During the six months ended June 30, 2023, the Company recorded ROU asset impairments of $0.8 million related to closing the 10th floor of its offices located in San Francisco and one other smaller office location. The impairments are included in restructuring and related costs in the Consolidated Statements of Operations. As a result of the impairments, the ROU assets were required to be recorded at their estimated fair values as Level 3 non-financial assets. The fair values of the asset groups were determined using a discounted cash flow model, which required the use of estimates, including projected cash flows for the related assets, the selection of a discount rate used in the model, and regional real estate industry data.

 

11


 

Note 6 – Revenue and Related Matters

Disaggregated Revenue

The Company disaggregates revenue as set forth in the following tables (in thousands):

Revenue by Geography

 

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

Revenues: (1)

 

2024

 

 

2023

 

 

2024

 

 

2023

 

North America

 

$

99,049

 

 

$

112,006

 

 

$

178,678

 

 

$

204,677

 

Europe

 

 

15,004

 

 

 

15,564

 

 

 

28,441

 

 

 

29,276

 

Asia Pacific

 

 

5,310

 

 

 

6,137

 

 

 

10,200

 

 

 

11,519

 

Other

 

 

2,462

 

 

 

1,882

 

 

 

4,583

 

 

 

3,787

 

Total

 

$

121,825

 

 

$

135,589

 

 

$

221,902

 

 

$

249,259

 

 

(1)
Revenue location is determined based on where the products and services are consumed.

Contract Assets and Contract Liabilities

Accounts Receivable

Accounts receivable includes amounts billed and currently due from customers. Since the only condition for payment of the Company’s invoices is the passage of time, a receivable is recorded on the date an invoice is issued. Also included in accounts receivable are unbilled amounts resulting from revenue exceeding the amount billed to the customer, where the right to payment is unconditional. If the right to payment for services performed was conditional on something other than the passage of time, the unbilled amount would be recorded as a separate contract asset. There were no contract assets as of June 30, 2024 or 2023.

The majority of the Company’s contracts are non-cancelable. However, for contracts that are cancelable by the customer, the Company does not record a receivable when it issues an invoice. The Company records accounts receivable on these contracts only up to the amount of revenue earned but not yet collected.

In addition, since the majority of the Company’s contracts are invoiced for annual periods, and payment is expected within one year from the transfer of products and services, the Company does not adjust its receivables or transaction prices for the effects of a significant financing component.

Deferred Revenue

The Company refers to contract liabilities as deferred revenue in the Consolidated Balance Sheets. Payment terms in the Company’s customer contracts vary, but generally require payment in advance of fully satisfying the performance obligation(s). Deferred revenue consists of billings in excess of revenue recognized. Similar to accounts receivable, the Company does not record deferred revenue for unpaid invoices issued on a cancelable contract.

 

During the three months ended June 30, 2024 and 2023, the Company recognized $47.9 million and $53.0 million of revenue, respectively, related to its deferred revenue balance at the beginning of each such period. During the six months ended June 30, 2024 and 2023, the Company recognized $110.4 million and $125.9 million of revenue, respectively, related to its deferred revenue balance at January 1 of each such period.

 

Approximately $359.6 million of revenue is expected to be recognized during the next 24 months from remaining performance obligations as of June 30, 2024.

Reserves for Credit Losses

The allowance for expected credit losses on accounts receivable for the six months ended June 30, 2024 is summarized as follows (in thousands):

 

 

Total
Allowance

 

Balance at December 31, 2023

 

$

574

 

Provision for expected credit losses

 

 

368

 

Write-offs

 

 

(189

)

Balance at June 30, 2024

 

$

753

 

When evaluating the adequacy of the allowance for expected credit losses, the Company makes judgments regarding the collectability of accounts receivable based, in part, on the Company’s historical loss rate experience, customer concentrations, management’s expectations of future losses as informed by current economic conditions, and changes in customer payment terms. If

 

12


 

the expected financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. If the expected financial condition of the Company’s customers were to improve, the allowances may be reduced accordingly.

Cost to Obtain Contracts